TWD 91.2
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 709.07 Million TWD | 16.91% |
2022 | 606.51 Million TWD | 13.05% |
2021 | 536.52 Million TWD | 6.22% |
2020 | 505.12 Million TWD | 38.43% |
2019 | 364.89 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 164.77 Million TWD | 0.0% |
2024 Q1 | 164.77 Million TWD | -10.83% |
2023 Q2 | 169.74 Million TWD | 0.0% |
2023 Q4 | 184.79 Million TWD | 0.0% |
2023 FY | 709.07 Million TWD | 16.91% |
2023 Q1 | 169.74 Million TWD | 4.64% |
2023 Q3 | 184.79 Million TWD | 8.87% |
2022 Q3 | 162.22 Million TWD | 0.0% |
2022 FY | 606.51 Million TWD | 13.05% |
2022 Q4 | 162.22 Million TWD | 0.0% |
2021 FY | 536.52 Million TWD | 6.22% |
2020 FY | 505.12 Million TWD | 38.43% |
2019 FY | 364.89 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | 1.576% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | 10.67% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -161.046% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 87.121% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 86.206% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 84.558% |
Center Laboratories, Inc. | 1.39 Billion TWD | 49.134% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -54.149% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | 20.321% |
InnoPharmax Inc. | 46.07 Million TWD | -1439.023% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -16.872% |
Excelsior Biopharma Inc. | 771.56 Million TWD | 8.099% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 53.907% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -263.557% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 35.907% |
UniPharma Co., Ltd. | 103.22 Million TWD | -586.941% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | 24.562% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | -51.101% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -68542.207% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -269.637% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | 12.559% |